Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

REMIFENTANIL vs REMIMAZOLAM: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

REMIFENTANIL vs REMIMAZOLAM: Safety Overview

Metric REMIFENTANIL REMIMAZOLAM
Total FAERS Reports 2,733 137
Deaths Reported 210 3
Death Rate 7.7% 2.2%
Hospitalizations 995 24
Average Patient Age 50.3 yrs 60.4 yrs
% Female Patients 48.2% 41.5%
FDA Approval Date Jan 16, 2018 Oct 6, 2020
Manufacturer Fresenius Kabi USA, LLC Acacia Pharma, Ltd.
Route INTRAVENOUS INTRAVENOUS
Marketing Status Prescription Prescription